Meningococcemia natural history, complications and prognosis

Jump to navigation Jump to search

Meningococcemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningococcemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Meningococcemia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Meningococcemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Meningococcemia natural history, complications and prognosis

CDC on Meningococcemia natural history, complications and prognosis

Meningococcemia natural history, complications and prognosis in the news

Blogs on Meningococcemia natural history, complications and prognosis

Directions to Hospitals Treating Meningococcemia

Risk calculators and risk factors for Meningococcemia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Natural History

  • Before antibiotics the case fatality rate was over 50%, particularly dangerous in infants and elderly (84% and 72% respectively). Now it is often as low as 8% in major medical centers.

Risk Stratification and Prognosis

  • Current vaccines have polysaccharides of groups A, C, Y, and W-135. No vaccine available presently for group B disease since the polysaccharide is not sufficiently immunogenic to produce a reliable antibody response in humans to be effective.
  • Rates of meningococcus in US college students as a whole 0.7 per 100,000.
  • Rates of meningococcus in US persons aged 18-23 not in college 1.5 per 100,000.
  • Rates of freshmen living in dormitories 4.6 per 100,000.
  • Rates for college students in UK 13.2 per 100,000 versus those not in college of 5.5 per 100,000.

References


Template:WikiDoc Sources